This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, Y. M. Articles by Hung, M.-C. Search for Related Content PubMed PubMed Citation Articles by Li, Y. M. Articles by Hung, M.-C.

Enhancement of Bik Antitumor Effect by Bik Mutants

¹ Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center,
² Graduate School of Biomedical Sciences, The University of Texas Health Science Center, Houston, Texas 77030

Bik was initially identified as a BH3-domain-only protein that interacts with E1B 19K. Although systemically administered wild-type Bik significantly inhibited tumor growth and metastasis in an orthotopic nude mouse model, the proapoptotic potency of Bik can be modulated by posttranslational phosphorylation. Here, we found that Bik mutants, in which threonine 33 and/or serine 35 were changed to aspartic acid to mimic the phosphorylation at these two residues, enhanced their binding affinity with the antiapoptotic proteins Bcl-X_L and Bcl-2 and were more potent than wild-type Bik in inducing apoptosis and inhibiting cell proliferation in various human cancer cells. Bik mutants also suppressed tumorigenicity and tumor-taking rate in a mouse ex vivo model. Moreover, Bik mutant-liposome complexes inhibited tumor growth and prolonged life span more effectively than the wild-type Bik-liposome complex in an in vivo orthotopic animal model. Thus, our results demonstrate that Bik mutant genes, more potent than wild-type Bik, induce cell death and suggest that their inhibition on the growth of various cancers should be explored further.

This article has been cited by other articles:

				T. Subramanian, S. Vijayalingam, E. Lomonosova, L.-j. Zhao, and G. Chinnadurai Evidence for Involvement of BH3-Only Proapoptotic Members in Adenovirus-Induced Apoptosis J. Virol., October 1, 2007; 81(19): 10486 - 10495. [Abstract] [Full Text] [PDF]

				Q. Ding, X. He, J.-M. Hsu, W. Xia, C.-T. Chen, L.-Y. Li, D.-F. Lee, J.-C. Liu, Q. Zhong, X. Wang, et al. Degradation of Mcl-1 by {beta}-TrCP Mediates Glycogen Synthase Kinase 3-Induced Tumor Suppression and Chemosensitization Mol. Cell. Biol., June 1, 2007; 27(11): 4006 - 4017. [Abstract] [Full Text] [PDF]

				Y. M. Li, B. P. Zhou, J. Deng, Y. Pan, N. Hay, and M.-C. Hung A Hypoxia-Independent Hypoxia-Inducible Factor-1 Activation Pathway Induced by Phosphatidylinositol-3 Kinase/Akt in HER2 Overexpressing Cells Cancer Res., April 15, 2005; 65(8): 3257 - 3263. [Abstract] [Full Text] [PDF]

				A. K. Ghosh, R. Steele, and R. B. Ray Carboxyl-Terminal Repressor Domain of MBP-1 is Sufficient for Regression of Prostate Tumor Growth in Nude Mice Cancer Res., February 1, 2005; 65(3): 718 - 721. [Abstract] [Full Text] [PDF]

				L. Ein-Dor, I. Kela, G. Getz, D. Givol, and E. Domany Outcome signature genes in breast cancer: is there a unique set? Bioinformatics, January 15, 2005; 21(2): 171 - 178. [Abstract] [Full Text] [PDF]